Related Experiment Video
Updated: Aug 12, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
Activating SRC mutation in a subset of advanced human colon cancers
1Department of Surgery, H. Lee Moffitt Cancer Center & Research Institute, University of South Florida College of Medicine, Tampa 33612, USA.
Activating mutations in the SRC gene are found in advanced colon cancer, promoting tumor growth and metastasis. This discovery provides genetic evidence for SRC
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Rous sarcoma virus (RSV) discovery led to cellular Src (c-Src), a non-receptor tyrosine kinase implicated in human cancers.
- c-Src is highly activated in colon cancers, especially those with liver metastasis.
- c-Src regulation involves carboxy-terminal tyrosine phosphorylation (Tyr 530), with implications for activating mutations.
Purpose of the Study:
- To identify and characterize activating mutations in the SRC gene in advanced human colon cancer.
- To investigate the role of these mutations in tumor progression, metastasis, and transformation.
Main Methods:
- Genetic analysis to identify mutations in the SRC gene in colon cancer patients.
- Functional assays to assess the kinase activity, transforming potential, tumorigenicity, and metastatic ability of the identified SRC mutation.
Main Results:
- A truncating mutation in SRC at codon 531 was identified in 12% of advanced colon cancer cases.
- This SRC mutation was demonstrated to be activating, transforming, tumorigenic, and to promote metastasis.
Conclusions:
- Activating SRC mutations, specifically the codon 531 truncation, play a role in the malignant progression of human colon cancer.
- This provides the first genetic evidence linking activating SRC mutations to colon cancer metastasis.
More Related Videos
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancers Originate from Somatic Mutations in a Single Cell
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...